$2.25
-0.06 (-2.60%)
Alexza Pharmaceuticals, Inc. (ALXA)
CAPS Rating:
An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

RSS Headlines
Fool UK